John V. Heymach | UT MD Anderson Top John V. Heymach, M.D., Ph.D. Department of Thoracic-Head & Neck Med Onc, Division of Cancer Medicine About Dr. Heymach Dr. Heymach is the Chair of Thoracic/Head and Neck Medical Oncology at MD Anderson Cancer Center. He holds the David Bruton …
RESEARCH ARTICLE Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia Haneen Banjar1,2*, Damith Ranasinghe1,3☯, Fred Brown1, David Adelson4, Trent Kroger1†, Tamara Leclercq5,6☯, Deborah White5,6,7,8,9‡, Timothy Hughes5,6,8,9…
Aytekin Erdoğan - Ege University Skip to main content Log In Sign Up About Press Papers Terms Privacy Copyright We're Hiring! Help Center Aytekin Erdoğan Ege University , Archaeology , Faculty Member Followers 301 Following 85 Public Views Interests Uploads Papers by Aytekin Erdo…
Heather Wakelee's Profile | Stanford Profiles Heather Wakelee Winston Chen and Phyllis Huang Professor Medicine - Oncology Practices at Stanford Health Care Print Profile Email Profile View Stanford-only Profile Tab Menu Bio Research & Scholarship Teaching Publications Bio Dr. He…
HISTORIE NIEKONWENCJONALNE Ewa Domañska HISTORIE NIEKONWENCJONALNE Refleksja o przesz³oœci w nowej humanistyce Wydawnictwo Poznañskie Poznañ 2006 © Copyright by Ewa Domañska, 2006 © Copyright by Wydawnictwo Poznañskie sp. z o.o., 2006 Redaktor: Mieczys³awa Makarowicz Projekt ok³a…
Abstract Purpose Assess efficacy and toxicity of gefitinib, an epidermal growth factor receptor (EGFR) inhibitor, added to, and in maintenance after, concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LA-HNC) and correlate outcomes with EGFR gene copy n…
Report Tumour genotyping for personalized cancer care Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine Dora Dias-Santagata1*, Sara Akhavanfard2y, Serena S. David2y, Kathy Vernovsky2, Georgiana Kuhlmann1, Susan L. Boisv…
US
Tyrosine kinase inhibitor-associated ventricular arrhythmias: a case series and review of literature
https://www.ncbi.nlm.nih.gov/pubmed/36411365
Background: Tyrosine kinase inhibitors (TKIs) have been increasingly used as first-line therapy in hematologic and solid-organ malignancies. Multiple TKIs have been linked with the development of cardiovascular complications, especially atrial arrhythmias, but data on ventricular…
Abstract The standard of care (SoC) for medically operable patients with early-stage (stages I–IIIB) NSCLC is surgery combined with (neo)adjuvant systemic therapy for patients with stages II to IIIB disease and some stage IB or, rarely, chemoradiation (stage III disease with medi…
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium. Clin Cancer Res. 2026 Mar 16; 32(6):1157-1168. Waliany S, Cooper AJ, Liu SV, Gautschi O, Rotow JK, Smith KER, Weber UM, Lee DH, Loon…
Papers by Piping Rahadianto TPM – Testing, Psychometrics, Methodology in Applied Psychology , 2026 It can be considered as a sociolinguistic phenomenon that always appear in every activity during ... more It can be considered as a sociolinguistic phenomenon that always appear in …
Elias Jabbour | UT MD Anderson Top Elias Jabbour, M.D. Department of Leukemia, Division of Cancer Medicine About Dr. Jabbour Dr. Jabbour joined the MD Anderson Cancer Center faculty in 2007 and is currently a Professor of Medicine in the Department of Leukemia. He is actively inv…
OLIVIERA CLÉMENT REINTERPRETACJA TEOLOGII UNIWERSYTET OPOLSKI * WYDZIA£ TEOLOGICZNY INSTYTUT EKUMENIZMU I BADAÑ NAD INTEGRACJ¥ Seria: EKUMENIZM I INTEGRACJA, NR 20 Ks. Dariusz S. Klejnowski-Ró¿ycki OLIVIERA CLÉMENT REINTERPRETACJA TEOLOGII Studium dogmatyczno-ekumeniczne REDAKCJA…
Scholarships | THE KNOWLEDGE INSTITUTE top of page TKI SCHOLARSHIP BLOG Featuring opportunities including: scholarships, fellowships, studentships training, development, STEM, short courses, online learning, and many others. If you are a high school student / teacher, university …
Introduction Clinical endpoints—such as overall survival and health-related quality of life—measure what is inherently meaningful to patients. In contrast, surrogate endpoints are stand-ins, measuring tumour growth rates or depth of tumour shrinkage, based on scans, serum protein…